| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/15/2008 | US20080113335 Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods |
| 05/15/2008 | US20080113334 Test method using cells and test kit therefor |
| 05/15/2008 | US20080113333 Using mixture comprising polyvinyl alcohol to prevent adhesion of cells and cellular components to surfaces |
| 05/15/2008 | US20080113332 Using prostate specific antigen concentration as diagnostic /prognostic indicator of prostate carcinoma |
| 05/15/2008 | US20080112979 Oral Killed Vaccines and Method for Providing Same |
| 05/15/2008 | US20080112978 Method For Treatment of Hiv Infection |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112956 Using membrane proteins concentration as cancer indicator |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/15/2008 | US20080112947 I kappa b kinase complex as a target for the treatment of huntington's disease |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | US20080112940 Using expression vector comprising nucleotide sequences coding intracellular domain of calcium transport protein as therapeutic in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112938 Transgenic stem cells expressing systemic interference defective-1 (SID-1) for use in gene expression aalysis |
| 05/15/2008 | US20080112930 Stent coated with sarcoplasmic reticulum calcium ATPase (SERCA) nucleotide sequences for use in treatment and prevention of vascular constriction |
| 05/15/2008 | US20080112889 Histone deacetylase 8 ( HDAC8); treating T-cell lymphoma by administering a population of autologous T-cells that have been exposed to a selective HDAC8 inhibitor composition ex vivo |
| 05/15/2008 | US20080112887 Pancreatitis |
| 05/15/2008 | DE102007045173A1 Nucleotide analogs useful for nucleic acid synthesis or sequencing comprise a nucleotide component, a sterically demanding macromolecular ligand, a label and a linker |
| 05/15/2008 | DE102006060717A1 Verfahren zur Aufreinigung wenigstens einer nachzuweisenden Zielsubstanz A process for purifying at least one target substance |
| 05/15/2008 | DE102006053385A1 Enterococcus faecalis- und/oder Enterococcus faecium-Antigen Enterococcus faecalis and / or Enterococcus faecium antigen |
| 05/15/2008 | DE102006053138A1 Predicting disease risk, disease progression and pharmaceutical drug risk and for identifying drug targets comprises looking for gene variations in the promoter region and/or intron 1 of the GNA11 gene |
| 05/15/2008 | DE102006052929A1 Diagnosis process for early tumor growth involves mixing thermally detoxified tetanus spores with transplantable tumor cells and injecting mixture into mice |
| 05/15/2008 | DE102006052916A1 Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM Diagnosis and risk stratification of diabetes mellitus by MR proADM |
| 05/15/2008 | DE102006035393A1 Prognostische Marker für die Klassifizierung des dreijährigen progessionsfreien Überlebens von Patienten mit Kolonkarzinomen basierend auf Expressionsprofilen von biologischen Proben Prognostic markers for the classification of the three-year progessionsfreien survival of patients with colon cancer based on expression profiles of biological samples |
| 05/15/2008 | DE102006035388A1 Prognostische Marker für die Klassifizierung von Kolonkarzinomen basierend auf Expressionsprofilen von biologischen Proben Prognostic markers for the classification of colon carcinoma based on expression profiling of biological samples |
| 05/15/2008 | DE102005007148B4 Verfahren und Array zur Replizierung und Analytik von Nukleinsäuren Method and array to replicate and analysis of nucleic acids |
| 05/15/2008 | CA2703810A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance |
| 05/15/2008 | CA2698826A1 New antigens for paratuberculosis diagnosis and vaccination |
| 05/15/2008 | CA2672201A1 Use of myb gene to diagnose and treat t-cell acute lumphoblastic leukemia |
| 05/15/2008 | CA2669260A1 Differential gene expression in physiological and pathological angiogenesis |
| 05/15/2008 | CA2669012A1 Methods and compositions for detecting receptor ligand mimetics |
| 05/15/2008 | CA2668998A1 Prediction of potential drug-drug interactions using gene expression profiling of drug transporters, cytochrome p450s and nuclear x receptors |
| 05/15/2008 | CA2668961A1 Spink1 as a prostate cancer marker and uses thereof |
| 05/15/2008 | CA2668955A1 Method for predicting therapeutic responsiveness to tnf-alpha blocking agents |
| 05/15/2008 | CA2668926A1 Process for determining dna fragmentation in microorganisms |
| 05/15/2008 | CA2668639A1 Device and process for assays using binding members |
| 05/15/2008 | CA2667914A1 Method for identifying modulators of the nrf2-keap1-are pathway |
| 05/15/2008 | CA2667809A1 Method for determining endoglycosidase (heparanase) enzyme activity |
| 05/15/2008 | CA2667521A1 Assay for metastatic colorectal cancer |
| 05/15/2008 | CA2666301A1 Snp detection and other methods for characterizing and treating bipolar disorder and other ailments |
| 05/15/2008 | CA2665164A1 Compositions and multiplex assays for measuring biological mediators of physiological health |
| 05/15/2008 | CA2664366A1 Slc1a1 antipsychotic drug response markers |
| 05/15/2008 | CA2637640A1 A magnetic resonance system and method to detect and confirm analytes |
| 05/14/2008 | EP1921171A1 Method for detecting cytosine methylation in DNA |
| 05/14/2008 | EP1921170A2 A method for determining the efficacy of an antharcycline anticancer agent and a device therefor |
| 05/14/2008 | EP1921169A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits |
| 05/14/2008 | EP1921168A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921167A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921166A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921165A1 Probe, Probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921164A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921163A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921162A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921161A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921160A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921159A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921158A1 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/14/2008 | EP1921157A2 Processes for detecting toxic substances |
| 05/14/2008 | EP1921156A1 Improved multiplex nucleic acid amplification using blocked primers |
| 05/14/2008 | EP1921155A1 Method for determination of protease activity in transglutaminase-containing matter and adhesive transglutaminase preparation |
| 05/14/2008 | EP1921154A1 Biosensor |
| 05/14/2008 | EP1921141A1 Novel artificial base pair and use thereof |
| 05/14/2008 | EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof |
| 05/14/2008 | EP1920253A2 Detection of proteases secreted from pathogenic microorganisms |
| 05/14/2008 | EP1920239A2 Detection and measurement of blood-feeding activity |
| 05/14/2008 | EP1920073A2 Method of simultaneously visualizing multiple biological targets |
| 05/14/2008 | EP1920072A2 In situ hybridization detection method |
| 05/14/2008 | EP1920071A2 Neoplastic disease-related methods, kits, systems and databases |
| 05/14/2008 | EP1920070A2 Self-contained biological analysis |
| 05/14/2008 | EP1920069A1 Differential expression gene profiles and applications in molecular staging of human gastric cancer |
| 05/14/2008 | EP1920068A1 Lupus anticoagulant testing |
| 05/14/2008 | EP1920067A2 Enzyme detection technique |
| 05/14/2008 | EP1920064A2 Compositions and methods for increasing amplification efficiency |
| 05/14/2008 | EP1920055A1 Method for extracting nucleic acid from blood |
| 05/14/2008 | EP1920054A1 Method for separating and purifying rna |
| 05/14/2008 | EP1920047A1 Method for the separation of living cells |
| 05/14/2008 | EP1920045A2 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 05/14/2008 | EP1919951A2 Anti-tnf-alpha antibodies and methods of use |
| 05/14/2008 | EP1919930A2 New nucleic acid base pairs |
| 05/14/2008 | EP1919503A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 05/14/2008 | EP1919286A2 Rapid saccharide biomarker assay |
| 05/14/2008 | EP1871894A4 The 1, 5-anhydroglucitol (1, 5-ag) assay and a1c/1. 5-ag assay combination for measuring blood glucose excursions in general and postprandial hyperglycemia in diabetic patients |
| 05/14/2008 | EP1869213A4 Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
| 05/14/2008 | EP1766025A4 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 05/14/2008 | EP1766021A4 Polynucleotides for the detection of escherichia coli 157:h7 and escherichia coli 0157:nm verotoxin producers |
| 05/14/2008 | EP1718769A4 Polony fluorescent in situ sequencing beads |
| 05/14/2008 | EP1709199A4 Direct identification and mapping of rna transcripts |
| 05/14/2008 | EP1704252B1 Polymorphisms of chromosome 9 implicated in premature canities |
| 05/14/2008 | EP1664764B1 Biosensors having reduced haemocrit effect |
| 05/14/2008 | EP1664332A4 Kinase and phosphatase assays |
| 05/14/2008 | EP1660674A4 Expression profiling using microarrays |
| 05/14/2008 | EP1633882B1 Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils) |
| 05/14/2008 | EP1623025B1 Glucose dehydrogenase and production thereof |
| 05/14/2008 | EP1490510B1 Novel primers for identifying aflatoxinogenic aspergilli and an improved use thereof |
| 05/14/2008 | EP1409712A4 Microfermentor device and cell based screening method |
| 05/14/2008 | EP1317568B1 Method of sequencing dna |
| 05/14/2008 | EP1269200B1 Method for prediction of preeclampsia and other diseases |
| 05/14/2008 | EP1261741B1 Method for the simultaneous detecting cytosine methylation and mutations in dna samples |
| 05/14/2008 | EP1259624B1 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 05/14/2008 | EP1250455B1 Antisense inhibition of ptp1b expression |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |